🇺🇸 FDA

Drug profile · INN

ceftaroline fosamil

ZINFORO

approved J01DI02
US status
approved
Patents linked
0
News articles
0

Quick answer

ceftaroline fosamil (ZINFORO) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

Key facts

INN ceftaroline fosamil
Brand ZINFORO
Route INTRAVENOUS
Formulation POWDER
ATC code J01DI02

Frequently asked questions

What is ceftaroline fosamil?

ceftaroline fosamil (ZINFORO) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

What is the brand name for ceftaroline fosamil?

ZINFORO is a marketed brand name for ceftaroline fosamil. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of ceftaroline fosamil?

ceftaroline fosamil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.